These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

303 related items for PubMed ID: 30064233

  • 1. Predictive value of microRNA-10b expression in peripheral blood mononuclear cells in evaluating short- and long-term efficacy of chemotherapy for patients with advanced non-small-cell lung cancer.
    Yang YL, Wang W, Xu LP.
    Neoplasma; 2018; 65(4):610-619. PubMed ID: 30064233
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Diagnostic Valuation of Serum miR-184 and miR-191 in Patients With Non-Small-Cell Lung Cancer.
    Ding H, Wen W, Ding Q, Zhao X.
    Cancer Control; 2020; 27(1):1073274820964783. PubMed ID: 33104396
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Investigation of serum miR-411 as a diagnosis and prognosis biomarker for non-small cell lung cancer.
    Wang SY, Li Y, Jiang YS, Li RZ.
    Eur Rev Med Pharmacol Sci; 2017 Sep; 21(18):4092-4097. PubMed ID: 29028091
    [Abstract] [Full Text] [Related]

  • 11. Circulating exosomal microRNAs as prognostic biomarkers for non-small-cell lung cancer.
    Liu Q, Yu Z, Yuan S, Xie W, Li C, Hu Z, Xiang Y, Wu N, Wu L, Bai L, Li Y.
    Oncotarget; 2017 Feb 21; 8(8):13048-13058. PubMed ID: 28055956
    [Abstract] [Full Text] [Related]

  • 12. High-Level Expression of microRNA-21 in Peripheral Blood Mononuclear Cells Is a Diagnostic and Prognostic Marker in Prostate Cancer.
    Huang W, Kang XL, Cen S, Wang Y, Chen X.
    Genet Test Mol Biomarkers; 2015 Sep 21; 19(9):469-75. PubMed ID: 26247873
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Upregulation of serum miR-494 predicts poor prognosis in non-small cell lung cancer patients.
    Zhang J, Wang T, Zhang Y, Wang H, Wu Y, Liu K, Pei C.
    Cancer Biomark; 2018 Sep 21; 21(4):763-768. PubMed ID: 29286916
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. microRNA miR-10b inhibition reduces cell proliferation and promotes apoptosis in non-small cell lung cancer (NSCLC) cells.
    Huang J, Sun C, Wang S, He Q, Li D.
    Mol Biosyst; 2015 Jul 21; 11(7):2051-9. PubMed ID: 25988292
    [Abstract] [Full Text] [Related]

  • 20. Down-regulation of microRNA-126 and microRNA-133b acts as novel predictor biomarkers in progression and metastasis of non small cell lung cancer.
    Chen SW, Wang TB, Tian YH, Zheng YG.
    Int J Clin Exp Pathol; 2015 Jul 21; 8(11):14983-8. PubMed ID: 26823832
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.